494 related articles for article (PubMed ID: 37802125)
21. Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling.
Mohamud Y; Fu C; Fan YM; Zhang YL; Lin JFC; Hwang SW; Wang ZC; Luo H
Antiviral Res; 2024 Feb; 222():105811. PubMed ID: 38242503
[TBL] [Abstract][Full Text] [Related]
22. Ectopic expression of cGAS in
Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.
Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT
J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789
[TBL] [Abstract][Full Text] [Related]
24. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
Guo J; Huang L
Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
[TBL] [Abstract][Full Text] [Related]
25. The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention.
Gong J; Gao X; Ge S; Li H; Wang R; Zhao L
Int J Biol Sci; 2024; 20(1):152-174. PubMed ID: 38164186
[TBL] [Abstract][Full Text] [Related]
26. cGAS-STING pathway in cancer biotherapy.
Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
[TBL] [Abstract][Full Text] [Related]
27. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity.
Tabar MMM; Fathi M; Kazemi F; Bazregari G; Ghasemian A
Mol Biol Rep; 2024 Apr; 51(1):487. PubMed ID: 38578532
[TBL] [Abstract][Full Text] [Related]
28. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
Wheeler OPG; Unterholzner L
Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
[TBL] [Abstract][Full Text] [Related]
29. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
[TBL] [Abstract][Full Text] [Related]
30. Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.
Seok JK; Kim M; Kang HC; Cho YY; Lee HS; Lee JY
Arch Pharm Res; 2023 Jun; 46(6):500-534. PubMed ID: 37354378
[TBL] [Abstract][Full Text] [Related]
31. DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells.
Li C; Liu W; Wang F; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Mol Immunol; 2021 Mar; 131():180-190. PubMed ID: 33423764
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
[TBL] [Abstract][Full Text] [Related]
33. Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy.
Zhou S; Su T; Cheng F; Cole J; Liu X; Zhang B; Alam S; Liu J; Zhu G
bioRxiv; 2023 Jul; ():. PubMed ID: 37502970
[TBL] [Abstract][Full Text] [Related]
34. Targeting Lymph Nodes for Systemic Immunosuppression Using Cell-Free-DNA-Scavenging And cGAS-Inhibiting Nanomedicine-In-Hydrogel for Rheumatoid Arthritis Immunotherapy.
Cheng F; Su T; Liu Y; Zhou S; Qi J; Guo W; Zhu G
Adv Sci (Weinh); 2023 Sep; 10(26):e2302575. PubMed ID: 37435620
[TBL] [Abstract][Full Text] [Related]
35. Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction.
Shi W; Xu G; Gao Y; Yang H; Liu T; Zhao J; Li H; Wei Z; Hou X; Chen Y; Wen J; Li C; Zhao J; Zhang P; Wang Z; Xiao X; Bai Z
Phytomedicine; 2024 Jun; 128():155404. PubMed ID: 38507852
[TBL] [Abstract][Full Text] [Related]
36. Significance of the cGAS-STING Pathway in Health and Disease.
Zhou J; Zhuang Z; Li J; Feng Z
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686127
[TBL] [Abstract][Full Text] [Related]
37. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders.
Huang Y; Liu B; Sinha SC; Amin S; Gan L
Mol Neurodegener; 2023 Nov; 18(1):79. PubMed ID: 37941028
[TBL] [Abstract][Full Text] [Related]
38. Role of the cGAS-STING pathway in systemic and organ-specific diseases.
Skopelja-Gardner S; An J; Elkon KB
Nat Rev Nephrol; 2022 Sep; 18(9):558-572. PubMed ID: 35732833
[TBL] [Abstract][Full Text] [Related]
39. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the activation and regulation of the cGAS-STING pathway.
Fang R; Jiang Q; Yu X; Zhao Z; Jiang Z
Adv Immunol; 2022; 156():55-102. PubMed ID: 36410875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
